Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: an ESTRO ACROP Delphi Consensus

Prostate cancer (PCa) is the second most frequent cancer diagnosis in men and the fifth leading cause of death worldwide 1. Nowadays, the increased prostate specific antigen (PSA) surveillance and new imaging tools such as multiparametric magnetic resonance imaging (mp-MRI) have significantly improved the detection of clinically relevant disease. Therefore, PCa is nowadays diagnosed at a relatively younger age, and the patients have consequently a longer lifetime and a higher risk of developing recurrence after the first treatment of the primary tumour.

Source: Cancer Treatment Reviews - April 19, 2021 Category: Cancer & Oncology Authors: Barbara A. Jereczek-Fossa, Giulia Marvaso, Mattia Zaffaroni, Simone Giovanni Gugliandolo, Dario Zerini, Federica Corso, Sara Gandini, Filippo Alongi, Alberto Bossi, Philip Cornford, Berardino De Bari, Val érie Fonteyne, Peter Hoskin, Bradley R. Pieters, Tags: Hot Topic Source Type: research